Analysis of markers such as lymphocyte cytosolic protein 2, autophagy and beclin 1 regulator 1 and loricrin opens new perspectives in understanding the role of the tumor microenvironment in melanoma progression. This evidence concerns the gene LORICRIN and melanoma.